Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical businesses, like the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use – and failure to do so may be grounds for compensation. Our lawyers are operating difficult to get these hurt by the drug the compensation they are entitled to.
Even though bleeding is really a common complication associated with anticoagulants, it has been alleged that Xarelto is much more harmful than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, within the occasion of an emergency, patients could be at threat for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.
If you or even a loved one particular suffered a significant bleeding event soon after taking Xarelto, you may have legal recourse. For more information, get in touch with us right now to have your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in situations of death, funeral costs. Furthermore, they are seeking punitive damages, that are usually awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
visit the next web page this page for far more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.